| 中文名 | (3aR,5R,6R,7R,7aR)-5-(乙酰氧基甲基)-2-甲基-5,6,7,7a-四氢-3aH-吡喃并[3,2-d]恶唑-6,7-二基二乙酸酯 |
|---|---|
| 英文名 | methyl (3,4,6-tri-O-acetyl-1,2-dideoxy-α-D-glucopyrano)-[2,1-D]-Δ2-oxazolidine |
| 中文别名 |
(3,5R,6R,7R,7-5-(乙酰氧基甲基)-2-甲基-5,6,7,7A-四氢-3AH-吡喃并[3,2-D]恶唑-6,7-二基二乙酸酯
化合物(6R)-FR054,10 MM DMSO 溶液 化合物(6R)-FR054 (3,7-5-(乙酰氧基甲基)-2-甲基-5,6,7,7A-四氢-3AH-吡喃并[3,2-D]噁唑-6,7-叉基二醋酸盐 |
| 英文别名 |
(3,7-5-(Acetoxymethyl)-2-Methyl-5,6,7,7A-Tetrahydro-3aH-Pyrano[3,2-D]Oxazole-6,7-Diyl Diacetate(WXC02555)
(3,7-5-(Acetoxymethyl)-2-methyl-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d][1,3]oxazole-6,7-diyl diacetate FR054 inhibit,ERS,(6R)-FR054,Inhibitor,(6R) FR054,Apoptosis,TNBC,(6R)-FR-054,cancer,breast,(6R)FR054 2-methyl-(3,4,6-tri-O-acetyl-1,2-dideoxy-α-D-glucopyranosido)-[2,1-d]-2-oxazoline (6R)-FR054, 10 mM in DMSO WXC02555 (3,5R,6R,7R,7-5-(acetoxymethyl)-2-methyl-3a,6,7,7a-tetrahydro-5H-pyrano[3,2-d]oxazole-6,7-diyl diacetate 3',4',6'-Triacetate 2'-Deoxy-2-methyl-4,5-D-galactopyrano-Δ2-oxazoline 4',5'-dihydro-2'-methoxyoxazolo[5',4':1,2]-3,4,6-tri-O-acetyl-1,2-dideoxy-α-D-glucopyranoside 4',5'-dihydro-2'-methyloxazolo[5',4':1,2]-3,4,6-tri-O-acetyl-1,2-dideoxy-α-D-glucopyranose (3,7-5-(ACETOXYMETHYL)-2-METHYL-5,6,7,7A-TETRAHYDRO-3AH-PYRANO[3,2-D]OXAZOLE-6,7-DIYL DIACETATE 2-methyl-(3,4,6-tri-O-acetyl-1,2-dideoxy-α-D-glucopyrano)-[2',1':4,5]-2-oxazoline (3,5R,6R,7R,7-5-(Acetoxymethyl)-2-methyl-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d]oxazole-6,7-diyl diacetate 5H-Pyrano[3,2-d]oxazole-6,7-diol, 5-[(acetyloxy)methyl]-3a,6,7,7a-tetrahydro-2-methyl-, 6,7-diacetate, (3,5R,6R,7R,7) 2-methyl-(3,4,6-tri-O-acetyl-1,2-dideoxy-α-D-glucopyrano)-<2,1-d>-2-oxazoline 2-methyl-(3,4,6-tri-O-acetyl-1,2-dideoxy-α-D-glucopyranoso)-[2,1-d]-2-oxazoline |
| 描述 | (6R)-FR054 是FR054 的一个活性异构体。FR054 是 HBP 酶 PGM3 的抑制剂,具有显著的抗乳腺癌活性。FR054 可诱导内质网应激和 ROS 依赖的细胞凋亡。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 分子式 | C14H19NO8 |
|---|---|
| 分子量 | 329.30300 |
| 精确质量 | 329.11100 |
| PSA | 109.72000 |
| 储存条件 | 2-8°C |
| 上游产品 0 | |
|---|---|
| 下游产品 9 | |